Federal Science Minister Fawad Chaudhry claimed on Friday (April 17) that the Drug Regulatory Authority of Pakistan (DRAP) didn’t check if t COVID-19 testing kits imported from China were made by specialized companies or not.
While speaking to a News channel Chaudhry said that the Sindh government’s claim that the testing kits provided by the NDMA were of sub-standard and lacked complete gear.
Chaudhry said, “When I asked [the DRAP CEO] about the certification of the kits, he said he hadn’t checked that because the authority was never asked to do so.”
Earlier on April 9, Special Assistant to the Prime Minister on National Health Services, Dr. Zafar Mirza has said Drug Regulatory Authority of Pakistan has allowed the local production of raw material of cholorquine as part of efforts to cope with coronavirus challenge.
In a statement today, he said the DRAP has also permitted clinical trials of plasma therapy for coronavirus treatment.
The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ventilators.
More than fifty companies allowed to produce sanitizers to contain the spread of the pandemic.